{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:02:32Z","timestamp":1786737752509,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/1319-2442.308326","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T08:25:37Z","timestamp":1611908737000},"page":"1180","source":"Crossref","is-referenced-by-count":2,"title":["Pregnancy-associated hemolytic uremic syndrome"],"prefix":"10.4103","volume":"31","author":[{"given":"Sami","family":"Alobaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"AlDabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"Alamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Almowarey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Akl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-2442.308326-1","first-page":"1679","article-title":"Atypical hemolytic uremic syndrome: From diagnosis to treatment","author":"Franchini","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"key-10.4103\/1319-2442.308326-2","first-page":"389","article-title":"Atypical hemolytic uremic syndrome (aHUS): New insights into pathogenesis leading to novel therapeutic approaches","author":"Kistler","year":"1994","journal-title":"Praxis (Bern"},{"key":"key-10.4103\/1319-2442.308326-3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ped.12274","article-title":"Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society","author":"Sawai","year":"2014","journal-title":"Pediatr Int"},{"key":"key-10.4103\/1319-2442.308326-4","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00467-016-3369-6","article-title":"Atypical hemolytic uremic syndrome: A clinical conundrum","author":"Bajracharya","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/1319-2442.308326-5","first-page":"641","article-title":"Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: Insights for optimizing management","author":"De","year":"2015","journal-title":"J Nephrol"},{"key":"key-10.4103\/1319-2442.308326-6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.308326-7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/asheducation.V2012.1.617.3798924","article-title":"Atypical hemolytic uremic syndrome: What is it, how is it diagnosed, and how is it treated?","author":"Nester","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key-10.4103\/1319-2442.308326-8","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.308326-9","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","author":"Sellier-Leclerc","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.308326-10","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/ndt\/gfq160","article-title":"Myocardial infarction is a complication of factor H-associated atypical HUS","author":"Sall\u00e9e","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.308326-11","first-page":"e125","article-title":"Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome","author":"Saad","year":"2016","journal-title":"AJP Rep"},{"key":"key-10.4103\/1319-2442.308326-12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/ped.13044","article-title":"Clinical guides for atypical hemolytic uremic syndrome in Japan","author":"Kato","year":"2016","journal-title":"Pediatr Int"},{"key":"key-10.4103\/1319-2442.308326-13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/ijerph13121209","article-title":"Association among complement factor H autoantibodies, deletions of CFHR, and the risk of atypical hemolytic uremic syndrome","author":"Jiang","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"key-10.4103\/1319-2442.308326-14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1681\/ASN.2013121339","article-title":"A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1\/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation","author":"Valoti","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.308326-15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000368591","article-title":"Complement and glomerular diseases","author":"Popat","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"key-10.4103\/1319-2442.308326-16","first-page":"774","article-title":"Thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome microangiopathy in pregnancy","author":"Scully","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"key-10.4103\/1319-2442.308326-17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs)","author":"Skerka","year":"2013","journal-title":"Mol Immunol"},{"key":"key-10.4103\/1319-2442.308326-18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","article-title":"Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome","author":"Greenbaum","year":"2016","journal-title":"Kidney Int"},{"key":"key-10.4103\/1319-2442.308326-19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"key-10.4103\/1319-2442.308326-20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/1319-2442.308326-21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40620-016-0288-3","article-title":"Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment","author":"Walle","year":"2017","journal-title":"J Nephrol"},{"key":"key-10.4103\/1319-2442.308326-22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2015.12.034","article-title":"Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: A single-arm, open-label trial","author":"Fakhouri","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/1319-2442.308326-23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nefro.2015.07.005","article-title":"An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment.A consensus document","author":"Campistol","year":"2015","journal-title":"Nefrologia"},{"key":"key-10.4103\/1319-2442.308326-24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"key-10.4103\/1319-2442.308326-25","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/ndt\/gfw314","article-title":"Atypical haemolytic uraemic syndrome and pregnancy: Outcome with ongoing eculizumab","author":"Servais","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.308326-26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1258\/om.2011.100059","article-title":"Pregnancy-associated atypical haemolytic uraemic syndrome in the post-partum period: A case report and review of the literature","author":"Egbor","year":"2011","journal-title":"Obstet Med"},{"key":"key-10.4103\/1319-2442.308326-27","first-page":"216","article-title":"Atypical hemolytic uremic syndrome: Differential diagnosis from TTP\/ HUS and management","author":"Yenerel","year":"2014","journal-title":"Turk J Haematol"},{"key":"key-10.4103\/1319-2442.308326-28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.06440616","article-title":"Pathogenic variants in complement genes and risk of atypical hemolytic uremic syndrome relapse after eculizumab discontinuation","author":"Fakhouri","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.308326-29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13730-019-00383-7","article-title":"Three months interval therapy of eculizumab in a patient with atypical hemolytic uremic syndrome with hybrid CFHR1\/CFH gene","author":"Alobaidi","year":"2019","journal-title":"CEN Case Rep"},{"key":"key-10.4103\/1319-2442.308326-30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1681\/ASN.2008080906","article-title":"Liver-kidney transplantation to cure atypical hemolytic uremic syndrome","author":"Saland","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.308326-31","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1600-6143.2012.04051.x","article-title":"Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH\/CFHR1 hybrid protein","author":"Krid","year":"2012","journal-title":"Am J Transplant"},{"key":"key-10.4103\/1319-2442.308326-32","first-page":"2917","article-title":"Kidney disease caused by dysregulation of the complement alternative pathway: An etiologic approach","author":"De","year":"2015","journal-title":"J Am Soc Nephrol"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:58:54Z","timestamp":1786733934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.308326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"alternative-id":["308326"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.308326","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}